First Look at Gilead Drug Virus Response to Open Data Floodgates

Published April 20, 2020

The first look at how well Gilead’s Ebola drug treats Covid-19 patients in an NIH clinical trial should come in a matter of weeks, the agency’s head said Monday.

Related Stories